147 related articles for article (PubMed ID: 2313975)
21. Deranged metabolism of lipids in patients with chronic renal failure: possible role of secondary hyperparathyroidism.
Nishizawa Y; Miki T; Okui Y; Matsushita Y; Inoue T; Morii H
Jpn J Med; 1986 Feb; 25(1):40-5. PubMed ID: 3712861
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone metabolism and its potential as a uremic toxin.
Slatopolsky E; Martin K; Hruska K
Am J Physiol; 1980 Jul; 239(1):F1-12. PubMed ID: 6994509
[TBL] [Abstract][Full Text] [Related]
23. Has parathyroid hormone any influence on lipid metabolism in chronic renal failure?
Arnadottir M; Nilsson-Ehle P
Nephrol Dial Transplant; 1995 Dec; 10(12):2381-2. PubMed ID: 8808260
[No Abstract] [Full Text] [Related]
24. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
25. Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle.
Smogorzewski M; Piskorska G; Borum PR; Massry SG
Kidney Int; 1988 Feb; 33(2):555-60. PubMed ID: 3361755
[TBL] [Abstract][Full Text] [Related]
26. Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.
Hruska KA; Korkor A; Martin K; Slatopolsky E
J Clin Invest; 1981 Mar; 67(3):885-92. PubMed ID: 7204561
[TBL] [Abstract][Full Text] [Related]
27. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure.
Tian J; Smogorzewski M; Kedes L; Massry SG
Am J Nephrol; 1994; 14(1):41-6. PubMed ID: 8017480
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
29. Lipid metabolism in acute renal failure.
Druml W; Laggner A; Widhalm K; Kleinberger G; Lenz K
Kidney Int Suppl; 1983 Dec; 16():S139-42. PubMed ID: 6588244
[TBL] [Abstract][Full Text] [Related]
30. Hyperlipidemia of chronic renal failure.
Kaysen GA
Blood Purif; 1994; 12(1):60-7. PubMed ID: 7986478
[TBL] [Abstract][Full Text] [Related]
31. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein abnormalities in chronic renal failure and dialysis patients.
Monzani G; Bergesio F; Ciuti R; Rosati A; Frizzi V; Serruto A; Vitali D; Benucci A; Tosi PL; Bandini S; Salvadori M
Blood Purif; 1996; 14(3):262-72. PubMed ID: 8738541
[TBL] [Abstract][Full Text] [Related]
33. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
[TBL] [Abstract][Full Text] [Related]
34. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K
Nephron; 1995; 70(2):242-8. PubMed ID: 7566311
[TBL] [Abstract][Full Text] [Related]
35. Effect of chronic renal failure on heart. Role of secondary hyperparathyroidism.
el-Belbessi S; Brautbar N; Anderson K; Campese VM; Massry SG
Am J Nephrol; 1986; 6(5):369-75. PubMed ID: 3826135
[TBL] [Abstract][Full Text] [Related]
36. Impaired insulin secretion of aging: role of renal failure and hyperparathyroidism.
Massry SG; Fadda GZ; Zhou XJ; Chandrasoma P; Cheng L; Filburn CR
Kidney Int; 1991 Oct; 40(4):662-7. PubMed ID: 1745015
[TBL] [Abstract][Full Text] [Related]
37. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
[TBL] [Abstract][Full Text] [Related]
38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
39. Secondary hyperparathyroidism in chronic renal failure.
Wills MR; Savory J
Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
[TBL] [Abstract][Full Text] [Related]
40. Lipids and apolipoproteins change during the progression of chronic renal failure.
Bergesio F; Monzani G; Ciuti R; Serruto A; Benucci A; Frizzi V; Salvadori M
Clin Nephrol; 1992 Nov; 38(5):264-70. PubMed ID: 1451339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
